NIH-funded research R01 grant

How bariatric surgery helps the liver heal by immune cells

Official title: Macrophages mediate the protective effects of bariatric surgery against steatohepatitis

Funded at University of Minnesota · NIH-11455274 · Data updated 2026-11-12

This grant explores how weight-loss surgery may protect the liver from fatty inflammation by changing liver immune cells.

More Bariatric Surgery research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 1, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$695,552
NIH project number1R01DK145728-01A1
Project IDNIH-11455274 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity and MAFLD/MASH who are considering or have had bariatric surgery, or who have related liver inflammation.

Less likely to help

People without obesity-related liver disease or those not considering bariatric surgery may not benefit from this research.

What this research studies

If you have obesity-related liver disease, this project looks at whether bariatric surgery can calm liver inflammation through repair-boosting immune cells in the liver. The researchers will study how surgeries like vertical sleeve gastrectomy affect liver fat, inflammation, and healing pathways over time. They plan to pinpoint macrophage-driven processes that might explain why some patients’ liver health improves after weight loss surgery. The work uses animal and human data to map immune changes and test ideas about reversing liver damage.

Why it matters

Potential benefit: Understanding these immune pathways could lead to new treatments that mimic surgery’s liver-protective effects for patients who can’t have surgery.

How similar studies have gone: Previous studies suggest weight loss and metabolic improvements can reduce liver inflammation, but the specific immune mechanisms in the liver are still being investigated.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Revelo, Xavier — University of Minnesota
  • Study coordinator: Revelo, Xavier

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.